These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 8277193

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Lack of cross-protection against diarrhea due to Vibrio cholerae O1 after oral immunization of rabbits with V. cholerae O139 Bengal.
    Albert MJ, Alam K, Rahman AS, Huda S, Sack RB.
    J Infect Dis; 1994 Mar; 169(3):709-10. PubMed ID: 8158063
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Evaluation of the protective efficacy of Vibrio cholerae ghost (VCG) candidate vaccines in rabbits.
    Eko FO, Schukovskaya T, Lotzmanova EY, Firstova VV, Emalyanova NV, Klueva SN, Kravtzov AL, Livanova LF, Kutyrev VV, Igietseme JU, Lubitz W.
    Vaccine; 2003 Sep 08; 21(25-26):3663-74. PubMed ID: 12922096
    [Abstract] [Full Text] [Related]

  • 6. Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination.
    Tacket CO, Cohen MB, Wasserman SS, Losonsky G, Livio S, Kotloff K, Edelman R, Kaper JB, Cryz SJ, Giannella RA, Schiff G, Levine MM.
    Infect Immun; 1999 Dec 08; 67(12):6341-5. PubMed ID: 10569747
    [Abstract] [Full Text] [Related]

  • 7. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.
    Shamsuzzaman S, Ahmed T, Mannoor K, Begum YA, Bardhan PK, Sack RB, Sack DA, Svennerholm AM, Holmgren J, Qadri F.
    Vaccine; 2009 Feb 25; 27(9):1386-92. PubMed ID: 19146897
    [Abstract] [Full Text] [Related]

  • 8. Oral vaccination with Lactococcus lactis expressing the Vibrio cholerae Wzm protein to enhance mucosal and systemic immunity.
    Zamri HF, Shamsudin MN, Rahim RA, Neela V.
    Vaccine; 2012 May 02; 30(21):3231-8. PubMed ID: 22426330
    [Abstract] [Full Text] [Related]

  • 9. PaxVax CVD 103-HgR single-dose live oral cholera vaccine.
    Levine MM, Chen WH, Kaper JB, Lock M, Danzig L, Gurwith M.
    Expert Rev Vaccines; 2017 Mar 02; 16(3):197-213. PubMed ID: 28165831
    [Abstract] [Full Text] [Related]

  • 10. Mucosal immunization with Vibrio cholerae outer membrane vesicles provides maternal protection mediated by antilipopolysaccharide antibodies that inhibit bacterial motility.
    Bishop AL, Schild S, Patimalla B, Klein B, Camilli A.
    Infect Immun; 2010 Oct 02; 78(10):4402-20. PubMed ID: 20679439
    [Abstract] [Full Text] [Related]

  • 11. A review of the current status of enteric vaccines.
    Levine MM, Noriega F.
    P N G Med J; 1995 Dec 02; 38(4):325-31. PubMed ID: 9522876
    [Abstract] [Full Text] [Related]

  • 12. Secondary Vibrio cholerae-specific cellular antibody responses following wild-type homologous challenge in people vaccinated with CVD 103-HgR live oral cholera vaccine: changes with time and lack of correlation with protection.
    Losonsky GA, Tacket CO, Wasserman SS, Kaper JB, Levine MM.
    Infect Immun; 1993 Feb 02; 61(2):729-33. PubMed ID: 8423098
    [Abstract] [Full Text] [Related]

  • 13. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
    Lebens M, Karlsson SL, Källgård S, Blomquist M, Ekman A, Nygren E, Holmgren J.
    Vaccine; 2011 Oct 06; 29(43):7505-13. PubMed ID: 21807059
    [Abstract] [Full Text] [Related]

  • 14. Onset and duration of protective immunity in challenged volunteers after vaccination with live oral cholera vaccine CVD 103-HgR.
    Tacket CO, Losonsky G, Nataro JP, Cryz SJ, Edelman R, Kaper JB, Levine MM.
    J Infect Dis; 1992 Oct 06; 166(4):837-41. PubMed ID: 1527420
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Immunogenicity and protective efficacy of a live, oral cholera vaccine formulation stored outside-the-cold-chain for 140 days.
    Xian TH, Sinniah K, Yean CY, Krishnamoorthy V, Bahari MB, Ravichandran M, Prabhakaran G.
    BMC Immunol; 2020 May 25; 21(1):29. PubMed ID: 32450807
    [Abstract] [Full Text] [Related]

  • 17. The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers.
    García L, Jidy MD, García H, Rodríguez BL, Fernández R, Año G, Cedré B, Valmaseda T, Suzarte E, Ramírez M, Pino Y, Campos J, Menéndez J, Valera R, González D, González I, Pérez O, Serrano T, Lastre M, Miralles F, Del Campo J, Maestre JL, Pérez JL, Talavera A, Pérez A, Marrero K, Ledón T, Fando R.
    Infect Immun; 2005 May 25; 73(5):3018-24. PubMed ID: 15845509
    [Abstract] [Full Text] [Related]

  • 18. Recombinant attenuated Vibrio cholerae strains used as live oral vaccines.
    Kaper JB, Levine MM.
    Res Microbiol; 1990 May 25; 141(7-8):901-6. PubMed ID: 2101480
    [Abstract] [Full Text] [Related]

  • 19. Live oral vaccines against cholera: an update.
    Levine MM, Kaper JB.
    Vaccine; 1993 May 25; 11(2):207-12. PubMed ID: 8438619
    [Abstract] [Full Text] [Related]

  • 20. Construction and evaluation of V. cholerae O139 mutant, VCUSM21P, as a safe live attenuated cholera vaccine.
    Murugaiah C, Nik Mohd Noor NZ, Mustafa S, Manickam R, Pattabhiraman L.
    PLoS One; 2014 May 25; 9(2):e81817. PubMed ID: 24505241
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.